Insider · CIK 0001251781

BRANDT GORDON

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001251781

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-06-29	PHASERX, INC.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2016-12-31	PHASERX, INC.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2016-08-19	PHASERX, INC.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2007-12-19	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award	President	AAward	+36K sh	$3.86	+$139K	129,699
2007-12-19	ATRXAdhera Therapeutics, Inc.A Award	President	AAward	+18K sh	—	—	40,504
2007-12-17	ATRXAdhera Therapeutics, Inc.F Tax Payment	President	FTax Payment	−661 sh	$3.60	−$2,379.6	22,504
2007-04-20	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsX Exercise of In-Money	President	XExercise of In-Money	−5,000 sh	$10.99	−$55K	93,699
2007-04-20	ATRXAdhera Therapeutics, Inc.M Exercise/Conversion	President	MExercise/Conversion	+5,000 sh	$10.99	+$55K	28,165
2007-04-20	ATRXAdhera Therapeutics, Inc.S Sale	President	SSale	−5,000 sh	$13.22	−$66.1K	23,165
2006-12-22	ATRXAdhera Therapeutics, Inc.S Sale	President	SSale	−675 sh	$15.67	−$10.6K	11,825
2006-07-06	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Common StockX Exercise of In-Money	President	XExercise of In-Money	−5,000 sh	$8.89	−$44.5K	115,000
2006-07-06	ATRXAdhera Therapeutics, Inc.S Sale	President	SSale	−5,000 sh	$15.43	−$77.1K	12,500
2006-07-06	ATRXAdhera Therapeutics, Inc.M Exercise/Conversion	President	MExercise/Conversion	+5,000 sh	$8.89	+$44.5K	17,500
2006-06-05	ATRXAdhera Therapeutics, Inc.S Sale	President	SSale	−5,000 sh	$14.81	−$74K	12,500
2006-06-05	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Common StockX Exercise of In-Money	President	XExercise of In-Money	−5,000 sh	$8.89	−$44.5K	120,000
2006-06-05	ATRXAdhera Therapeutics, Inc.M Exercise/Conversion	President	MExercise/Conversion	+5,000 sh	$8.89	+$44.5K	17,500
2005-01-21	ATRXAdhera Therapeutics, Inc.A Award	President	AAward	+7,500 sh	—	—	7,500
2005-01-21	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Stock OptionsA Award	President	AAward	+7,500 sh	$10.39	+$77.9K	122,500

Recent filings

Accepted (ET)
Jun 294
PHASERX, INC.0001144204-17-035008
SEC(opens sec.gov)
Jan 34
PHASERX, INC.0001144204-17-000264
SEC(opens sec.gov)
Aug 234
PHASERX, INC.0001144204-16-120807
SEC(opens sec.gov)
Dec 204
BRANDT GORDON0001209191-07-071181
SEC(opens sec.gov)
Apr 244
NASTECH PHARMACEUTICAL CO INC0001209191-07-025228
SEC(opens sec.gov)
Dec 224
NASTECH PHARMACEUTICAL CO INC0001209191-06-066821
SEC(opens sec.gov)
Jul 64
NASTECH PHARMACEUTICAL CO INC0001209191-06-040268
SEC(opens sec.gov)
Jun 54
BRANDT GORDON0001209191-06-034683
SEC(opens sec.gov)
Jan 254
BRANDT GORDON0001209191-05-004717
SEC(opens sec.gov)

Companies

Address

410 WEST HARRISON STREET SUITE 300

SEATTLE, WA, 98119